December 02, 2009 11:12 ET

Department of Justice Demand for Open Playing Field for Medical Waste Likely to Help MedClean Technologies (OTCBB: MCLN)

LOS ANGELES, CA--(Marketwire - December 2, 2009) - BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has issued a special report on MedClean Technologies (OTCBB: MCLN).

In breaking news that will likely impact the stock price of smaller medical waste companies, sector leader Stericycle, Inc. says it has agreed to a Department of Justice demand to sell off some of its medical waste collection businesses in four states to settle an antitrust lawsuit and finalize its $182.5 million acquisition of MedServe Inc.

The development will likely impact the financial outlook and prices of other smaller companies which have been fighting to compete for a bigger share of the multi-billion dollar medical waste sector.

BioMedReports readers were introduced this week to one such company, MedClean Technologies (OTCBB: MCLN). MCLN shares currently trade at vastly undervalued levels -- mostly due to their only recent arrival into the market. That company, in particular, appears poised to continue its own growth within the sector because it is one of the more well-equipped and organized companies to do so and biomedical investors appear to be taking note of it.

Unlike its competitors, MedClean provides on-site treatment solutions and fixed installations that fit within healthcare institutions' physical facilities whereas Stericycle, Medserve and others offer hospitals their service via a network of processing and collection sites.

Recently, President Barack Obama also made it clear that he would like to see hospitals and healthcare facilities in the U.S. become more "self-sufficient." He urged health industry leaders to find more ways for these facilities to function efficiently for prolonged periods without the need for outside services in the event of a national disaster or emergency situation. That news bodes well for MedClean as well.

The complete report is available now at BioMedReports.Com:

Biotech investors interested in accessing the news portal's complete database of clinical trials and upcoming FDA decisions can access that information here:

About BioMedReports.Com is a news portal covering the biomedical news and financial sector. BioMedReports is not paid, compensated or in any way incentivized to report news and developments about publicly traded companies.

For more biomedical sector and investment news go to

Contact Information

  • Media Contact:
    Mary Davila
    Assistant Editor
    e-mail: Email Contact
    Tel: +1 323 472 4480
    Fax: +1 888 210 3556